12,090 Amdocs Limited $DOX Shares Purchased by Ethic Inc.

Ethic Inc. increased its stake in shares of Amdocs Limited (NASDAQ:DOX) by 117.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,384 shares of the technology company’s stock after acquiring an additional 12,090 shares during the quarter. Ethic Inc.’s holdings in Amdocs were worth $1,280,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Alpine Bank Wealth Management boosted its position in shares of Amdocs by 58.2% in the 3rd quarter. Alpine Bank Wealth Management now owns 500 shares of the technology company’s stock valued at $29,000 after purchasing an additional 184 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Amdocs during the third quarter worth about $57,000. Versant Capital Management Inc increased its position in Amdocs by 3,340.6% in the 3rd quarter. Versant Capital Management Inc now owns 1,101 shares of the technology company’s stock valued at $63,000 after acquiring an additional 1,069 shares during the period. Farther Finance Advisors LLC increased its position in Amdocs by 16.4% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,292 shares of the technology company’s stock valued at $74,000 after acquiring an additional 182 shares during the period. Finally, GAMMA Investing LLC raised its stake in Amdocs by 65.7% during the 2nd quarter. GAMMA Investing LLC now owns 1,725 shares of the technology company’s stock valued at $87,000 after acquiring an additional 684 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

DOX has been the topic of a number of analyst reports. Wall Street Zen downgraded Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, November 7th. Weiss Ratings upgraded shares of Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 23rd. Oppenheimer lowered Amdocs from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 4th. Zacks Research lowered shares of Amdocs from a “hold” rating to a “strong sell” rating in a research note on Monday, November 9th. Finally, Stifel Nicolaus lowered their target price on shares of Amdocs from $71.00 to $46.00 and set a “buy” rating on the stock in a research note on Wednesday, November 4th. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $69.00.

Insider Activity

In related news, insider Shimie Hortig sold 1,733 shares of the firm’s stock in a transaction that occurred on Wednesday, November 11th. The stock was sold at an average price of $43.14, for a total transaction of $74,761.62. Following the completion of the transaction, the insider owned 172,699 shares in the company, valued at $7,450,234.86. This trade represents a 0.99% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John Anthony Macdonald purchased 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 10th. The stock was bought at an average cost of $41.63 per share, for a total transaction of $41,630.00. Following the purchase, the director owned 25,189 shares in the company, valued at $1,048,618.07. This represents a 4.13% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have bought 3,534 shares of company stock worth $147,966. Company insiders own 15.40% of the company’s stock.

Amdocs Stock Up 1.5%

DOX stock opened at $44.79 on Friday. Amdocs Limited has a 1 year low of $39.96 and a 1 year high of $84.95. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23. The company has a fifty day simple moving average of $57.51 and a 200 day simple moving average of $60.98. The firm has a market cap of $4.84 billion, a PE ratio of 9.59, a PEG ratio of 1.44 and a beta of 0.42.

Amdocs (NASDAQ:DOX) last released its quarterly earnings results on Tuesday, November 3rd. The technology company reported $1.98 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.98. The company had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.19 billion. Amdocs had a net margin of 10.59% and a return on equity of 20.81%. The business’s quarterly revenue was up 3.8% compared to the same quarter last year. During the same period in the prior year, the company earned $1.83 earnings per share. Sell-side analysts anticipate that Amdocs Limited will post 5.82 EPS for the current fiscal year.

Amdocs Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be issued a dividend of $0.5690 per share. This represents a $2.28 annualized dividend and a dividend yield of 5.1%. The ex-dividend date of this dividend is Thursday, December 31st. Amdocs’s dividend payout ratio (DPR) is presently 48.82%.

Key Headlines Impacting Amdocs

Investors following DOX have been watching these headlines:

• Positive Sentiment: Three directors reported purchases of Amdocs shares, including Yvette Kanouff’s $100,800 purchase and John Anthony Macdonald’s $41,630 purchase. These transactions may signal confidence in the company, although insider buying is not a guarantee of future performance. SEC filing
• Positive Sentiment: Amdocs is seeking shareholder approval for a 3% quarterly dividend increase, which could bolster its appeal to income-focused investors. Dividend proposal
• Negative Sentiment: Law firms announced investigations into potential securities claims after Amdocs’ significant stock drop. These are investigations, not findings of wrongdoing, but add uncertainty. The recent selloff followed disappointing fiscal 2027 guidance tied to an escalating T-Mobile dispute, despite quarterly earnings and revenue matching consensus. Investigation announcement

Amdocs Company Profile

Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.